Ghosh, S., Seshadri, R., and Jain, K. C. (1971) . Archives of Disease in Childhood, 46, 51. Evaluation of corticosteroids in treatment of tuberculous meningitis. 98 patients with tuberculous meningitis were studied with a view to assessing the value of steroids as an adjuvant to antitubercular drugs. The patients were divided into three groups irrespective of the clinical stage of the disease. One group received antitubercular drugs alone, the second oral prednisolone, and the third intrathecal steroids, in addition to the antitubercular drugs. There was no significant difference in the mortality rate in the different groups. Oral steroid treatment lowered the CSF protein more rapidly, but did not influence the outcome nor prevent the formation of spinal block.
Steroids have been used as an adjuvant in the treatment of tuberculous meningitis since 1953. Experimentally, steroids suppress certain aspects of the inflammatory response in tuberculosis (Ebert, 1952) and have been proposed as an adjuvant in the treatment of tuberculous meningitis. Steroids have been administered either orally, parenterally, or intrathecally. Reports on the therapeutic efficacy of steroids are conflicting, with only two attempts at a controlled study (Lepper and Spies, 1963; O'Toole et al., 1969) . This study was undertaken to assess the value of steroids, either oral or intrathecal, as an adjuvant in the treatment of tuberculous meningitis. Group II: (a) antitubercular treatment as in Group I above; (b) prednisolone (2 mg/kg per day orally for six weeks).
Group III: (a) antitubercular treatment as in Group I; (b) hydrocortisone intrathecally (25 mg/kg per day for 6 days). Table I shows the distribution of patients according to the treatment groups, with the mortality.
When first seen, of the 98 cases, 50 had convulsions, 31 generalized spasticity. Other neurological complications are detailed in Table II . of steroids to the treatment of tuberculous meningitis seemed to have significantly reduced the mortality from tuberculous meningitis. She had compared this result with that of 117 patients treated in 1962, of whom only 38 patients had received steroids. Ashby and Grant (1955) , Bulkeley (1953), and Voljavec and Corpe (1960) reported similar improved survival in steroid treated patients, attributing this to the reduction in the meningeal inflammation and to a decrease in the reduction of spinal block. Lepper and Spies (1963) (Wasz-Hockert, 1962) . Toole and McCall (1969) Shane and Riley, 1953) was confirmed. But whether this reduction in the protein decreases the incidence of spinal block has not been shown. In this study two patients developed spinal block during treatment with steroids (Group II) and the simultaneous administration of intrathecal steroid did not affect the course.
